Future Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 50.8% | 1.229 | Q1 | 88.5% |
| 2024 | 2.6 | Q3 | 44.8% | 1.052 | Q1 | 85.5% |
| 2023 | 3.0 | Q2 | 52.4% | 1.029 | Q1 | 86.2% |
| 2022 | 3.3 | Q3 | 48.4% | 0.874 | Q1 | 83.0% |
| 2021 | 3.7 | Q3 | 50.8% | 0.836 | Q2 | 82.3% |
| 2020 | — | — | 0.857 | Q2 | 81.6% | |
| 2019 | — | — | 0.837 | Q2 | 81.4% | |
| 2018 | — | — | 0.797 | Q2 | 78.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1479-6694
ISSN
1744-8301
region
Western Europe
coverage
2005-2026